Could Asthma Drug Fight Alzheimer's?

A study out of Temple University has found that the asthma drug Zileuton (5-lipoxygenase) helps reduce the formation of beta amyloid, a brain peptide linked to the development of Alzheimer's disease.

The researchers found that 5-lipoxygenase controls the part of the brain responsible for the production of beta amyloid. Alzheimer's specialists measure the levels of beta-amyloid plaques in the brain to determine the severity of Alzheimer's disease.

Since Zileuton is already FDA-approved, the researchers are hopeful that clinical trials involving for new applications of the drug could begin quickly.

To learn more, click here.